Evidence map›Paper›PMID 41256699›Full record

ArticlebioRxiv : the preprint server for biology2025

Latent plasticity of the human pancreas across development, health, and disease.

Elisabetta Mereu, Diego Balboa, Johannes Liebig, Aitor Gonzalez-Herrero, Anna Martinez-Casals, Mariya Mardamshina, Fanny Mollandin, Felix Schicktanz, Luca Tosti, Valerie Vandenbempt and 34 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors.

Elisabetta MereuJosep Carreras Leukemia Research Institute, Barcelona, Spain.ORCID 0000-0001-6101-8472
Diego BalboaCentre for Genomic Regulation, the Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0002-4784-5452
Johannes LiebigBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0002-9188-036X
Aitor Gonzalez-HerreroJosep Carreras Leukemia Research Institute, Barcelona, Spain.ORCID 0000-0002-2644-8028
Anna Martinez-CasalsDepartment of Bioengineering, Stanford University, Stanford, CA, USA.ORCID 0000-0003-2722-1965
Mariya MardamshinaDepartment of Bioengineering, Stanford University, Stanford, CA, USA.
Fanny MollandinCentre for Genomic Regulation, the Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003, Barcelona, Spain.
Felix SchicktanzInstitute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Luca TostiBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.
Valerie VandenbemptStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
Dana AvrahamiDepartment of Developmental Biology and Cancer Research, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Edgar BernardoCentre for Genomic Regulation, the Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003, Barcelona, Spain.
Frida BjörklundDepartment of Bioengineering, Stanford University, Stanford, CA, USA.
Robert Lorenz ChuaBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.
Marten EngelseDepartment of Internal Medicine, Leiden University Medical Center (LUMC); Leiden, The Netherlands.
Javier García-HurtadoCentre for Genomic Regulation, the Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003, Barcelona, Spain.
Nathalie GroenDepartment of Internal Medicine, Leiden University Medical Center (LUMC); Leiden, The Netherlands.
Maaike HanegraafDepartment of Internal Medicine, Leiden University Medical Center (LUMC); Leiden, The Netherlands.
Pablo IañezJosep Carreras Leukemia Research Institute, Barcelona, Spain.
Katharina JechowBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.
Björn KonukiewitzInstitute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Christian LawerenzSteinbeis Transfer GmbH, Center Health Data, Stuttgart, Germany.
Domenica MarcheseCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Mauro J MuraroSingle Cell Discoveries, Utrecht, the Netherlands.
Silvia PellegriniDiabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Valeria SordiDiabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Alexander SudyBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.
Ulrike TaronBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.
Foo Wei TenBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.
Timo TrefzerBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.
Sven TwardziokBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.
Maarten van AgenDepartment of Internal Medicine, Leiden University Medical Center (LUMC); Leiden, The Netherlands.
Françoise CarlottiDepartment of Internal Medicine, Leiden University Medical Center (LUMC); Leiden, The Netherlands.
Eelco de KoningDepartment of Internal Medicine, Leiden University Medical Center (LUMC); Leiden, The Netherlands.
Jorge FerrerCentre for Genomic Regulation, the Barcelona Institute of Science and Technology, Dr. Aiguader 88, 08003, Barcelona, Spain.
Benjamin GlaserDepartment of Endocrinology and Metabolism, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Israel.
Holger HeynUniversitat de Barcelona, Barcelona, Spain.
Emma LundbergDepartment of Bioengineering, Stanford University, Stanford, CA, USA.
Lorenzo PiemontiSingle Cell Discoveries, Utrecht, the Netherlands.
Katja SteigerComparative Experimental Pathology, Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Alexander van OudenaardenHubrecht Institute, Royal Netherlands Academy of Arts and Sciences, and University Medical Center, Utrecht, the Netherlands.
Wilko WeichertInstitute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Christian ConradBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0001-7036-342X
Roland EilsBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0002-0034-4036

Funding

The Human Islet Distribution Coordinating Center (UC4)UC4DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI EVANS-MOLINA, CARMELLA, NILAND, JOYCE CAROL · 2012 to 2017
$25.6M
NIDDK NIH HHS UC4 DK098085
6 · The paper itself

Abstract

The pancreas plays a central role in major human diseases, yet our understanding of its cellular diversity and plasticity remains incomplete. Here, we present a single-cell multiomics atlas of the human pancreas, profiling over four million cells and nuclei from 57 donors across fetal development, adult homeostasis, and type 2 diabetes (T2D). Integrating sc/snRNA-seq, snATAC-seq, VASA-seq, spatial transcriptomics (Xenium), and multiplexed proteomics (CODEX), we resolve gene expression, chromatin accessibility, and spatial organization at high resolution. We identify transcriptionally plastic centroacinar-like cells (pCACs) in adults with fetal-like features, delineate endocrine and exocrine lineage trajectories during development, and uncover HNF1A-defined beta cell epigenetic states. In T2D, we observe shifts in beta cell subtypes and altered regulatory programs. Glucose perturbation of healthy islets reveals cell-type-specific adaptation and stress responses. This atlas provides a foundational framework to understand pancreas biology and the role of cellular plasticity in regeneration and disease.

Identifiers

PMID41256699
PMCPMC12622017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.